ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Bioorganic & Medicinal Chemistry
Volume 13, Issue 22, 15 November 2005, Pages 6182-6187
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (241 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bmc.2005.06.029    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2005 Elsevier Ltd All rights reserved.

Cyclopentenediones, inhibitors of farnesyl protein transferase and anti-tumor compounds, isolated from the fruit of Lindera erythrocarpa Makino

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Hyun-Mi Oha, b, , Sung-Kyu Choia, , Ji Min Leea, Su-Kyung Leea, Hak-Yung Kimb, Dong Cho Hana, Hwan-Mook Kima, Kwang-Hee Sona, Corresponding Author Contact Information, E-mail The Corresponding Author and Byoung-Mog Kwona, c, Corresponding Author Contact Information, E-mail The Corresponding Author

aKorea Research Institute of Bioscience and Biotechnology, 52 Uendong Yoosung, Taejeon 305-600, Republic of Korea

bDepartment of Biochemistry, Chungbuk National University, Cheongju 360-763, Republic of Korea

cUniversity of Science and Technology in Korea, Taejeon 305, Republic of Korea


Received 4 May 2005; 
revised 15 June 2005; 
accepted 16 June 2005. 
Available online 1 August 2005.

Abstract

Four cyclopentenediones, farnesyl protein transferase inhibitors, and anti-tumor compounds were isolated from the methanolic extract of the fruits of Lindera erythrocarpa Makino (Lauraceae). The structure of the compounds was determined by spectral data including NMR and mass spectrometry, and cyclopentenediones such as methyllinderone (1), methyllucidone (2), lucidone (3), and linderone (4) were identified by comparing their reported spectral data with that of the literature values. Compounds 14 inhibited farnesyl protein transferase with IC50 value of 55.3 ± 4.1, 42 ± 1.9, 103 ± 5.1, and 40 ± 3.5 μM, respectively. Isolated compounds also inhibited the growth of various human cancer cell lines in a dose-dependent manner. Especially, Compounds 1 and 2 selectively inhibited the growth of H-ras-transformed rat-2 cell lines in comparison with normal rat-2 cells with a GI50 value of 0.3 and 0.85 μM, respectively. Methyllucidone strongly inhibited the growth of human cancer cells and colon tumor xenografted in nude mice. The anti-tumor effects of the compound were further confirmed with caspase-3 activation and degradation of PARP. The results suggest that methyllucidone can be a potential anti-cancer agent against H-ras-transformed tumor and will also be a good lead molecule for the development of anti-tumor drug.

Graphical abstract

Cyclopenetendiones were isolated from the fruits of Lindera erythrocarpa. Cyclopentendiones strongly inhibited the growth of human tumor and H-ras-transformed rat-2 cells.

Full-size image

Keywords: Cyclopentenediones; Farnesyl protein transferase; Anti-tumor; Lindera erythrocarpa

Article Outline

1. Introduction
2. Results and discussion
2.1. Isolation and FPTase inhibition activity
2.2. In vitro anti-tumor activity
2.3. Methyllucidone (2) induces apoptosis in human colon cancer cell lines
2.4. In vivo anti-tumor activity
3. Conclusion
4. Experimental
4.1. General
4.2. Plant material
4.3. FPTase activity assay
4.4. Extraction and isolation
4.4.1. Methyllinederone (1)
4.4.2. Methyllucidone (2)
4.4.3. Lucidone (3)
4.4.4. Linderone (4)
4.5. Cell growth inhibition assay
4.6. Western blotting
4.7. In vivo activities of methyllucidone
Acknowledgements
References







Corresponding Author Contact InformationCorresponding authors. Tel.: +82 42 860 4557; fax: +82 42 861 2675.
 These authors contributed equally to this work.

Bioorganic & Medicinal Chemistry
Volume 13, Issue 22, 15 November 2005, Pages 6182-6187
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.